HealthTree Logo
search more_vert
person Sign In / Create Account
Cancer-Related Cognitive Impairment: Strategies and Support
Cancer-Related Cognitive Impairment: Strategies and Support  image
Adult AML Chapter
event Nov 13, 2023 / 01:30PM - 02:30PM EST

Video Recording Coming Soon

Event Description

Dr. Topalian will share what cancer-related cognitive impairment (chemo-brain) is, what it means for patients, and strategies on how to best live with it.

Schedule & Agenda

The panelist Mary Arnett
1:30 PM
Mary Arnett

Mary introduces the event's agenda and featured speaker Dr. Alique Topalian.

The panelist Alique Topalian
1:35 PM
Alique Topalian

Dr. Topalian shares what cancer-related cognitive impairment (chemo-brain) is and shares strategies and support to help patients best live with it. 

The panelist Audience
Questions and Answers
2:05 PM

Type your questions in the chat and Dr. Topalian will answer them!


Speakers & Moderators

The panelist Mary Arnett
Mary Arnett
Salt Lake City, UT

Mary joined HealthTree in 2022. She is now the AML & MDS Community and Education Manager. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't advocating for patients, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.

Read Bio
The panelist Alique Topalian
Alique Topalian

Alique Topalian is a 2-time cancer survivor. She was first diagnosed with AML in 1998 at age 4 and relapsed in March of 2021 at age 27. She is now in remission and using her voice to passionately raise awareness about the unique needs of cancer patients. At age 7, she began to advocate for childhood cancers and raise awareness about bone marrow and cord blood donation. Since 2000, she has been the mascot, spokesperson, and fundraiser for the Armenian Bone Marrow Registry. Her experience with childhood cancer inspired her to obtain a Master’s in Public Health and a Ph.D. in Health Promotion and Education completing her degree in 2020. Her research focused on mental and behavioral health examining protective factors and resiliency. Little did she know that in March of 2021 she would relapse with AML, the first person to ever relapse after 22 years. During her time in active treatment, she used every opportunity to network, participate in psychosocial programming, and educate herself on resources available to patients in all stages of treatment. Since her relapse, Alique is speaking at national and local conferences, using social media and other forms of communication to give AYA cancer patients a voice. Alique was selected as a 2022 recipient of the 40 Under 40 in Cancer award. She is sharing her recent experience with The University of Cincinnati as a Research Scientist to research patient experience, AYAs, and survivorship. Her life’s focus and passion have grown as a result of her relapse and she is determined to improve the lives of others.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us




Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Astellas Pharma

Follow Us

facebook instagram linkedin tiktok youtube